Upcoming Conferences in Boston, United States

2024 has revitalized the bacteriophage field, with over $9 Million invested into BiomX and Locus Bioscience; $24 Million dedicated by BARDA to prog...

As the cell and gene therapy (CGT) pipeline matures and new, exciting technologies scale into the clinic, the success of delivering the growing num...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. With the field anticipating finalized reg...

The transformative era of kidney drug development is here, with 2024 bringing landmark advancements, including Novartis' Borealis Biosciences and a...

Global biopharmaceutical leaders continue to make significant strides in retinal disease treatments; as Bayer and Regeneron make headway with its h...

In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements ...

Expanded Access Programs (EAPs) are increasingly recognized as an ethical imperative in modern healthcare. More companies are opening EAPs to provi...

As the biopharmaceutical industry continues to rely on alliances and collaboration with external organizations to access innovation and obtain mark...

Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies l...

Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene th...

Welcome to the 4th Novel Conjugates Summit! We are witnessing a surging 83% growth of novel drug conjugates, with major collaborations between N...

With the plasmid DNA manufacturing market set to rise to $39.3Bn by 2033, and the demand for advanced therapies continuing to surge as gene therapy...